These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3585320)

  • 21. Apomorphine-induced inhibition of striatal dopamine release: role of dopaminergic receptors in substantia nigra.
    Maggi A; Bruno F; Cattabeni F; Groppetti A; Parenti M; Racagni G
    Brain Res; 1978 Apr; 145(1):180-4. PubMed ID: 205324
    [No Abstract]   [Full Text] [Related]  

  • 22. Acute and chronic effects of neuroleptics and acute effects of apomorphine and amphetamine on dopamine turnover in corpus striatum and substantia nigra of the rat brain.
    Nicolaou NM
    Eur J Pharmacol; 1980 Jun; 64(2-3):123-32. PubMed ID: 6105080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of chronic haloperidol administration on GABA receptor binding.
    Huffman RD; Ticku MK
    Pharmacol Biochem Behav; 1983 Aug; 19(2):199-204. PubMed ID: 6314387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
    Wilmot CA; Szczepanik AM
    Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum.
    Nissbrandt H; Sundström E; Jonsson G; Hjorth S; Carlsson A
    J Neurochem; 1989 Apr; 52(4):1170-82. PubMed ID: 2564423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The striatonigral fibres and the feedback control of dopamine metabolism.
    Tulloch IF; Arbuthnott GW; Wright AK; Garcia-Munoz M; Nicolaou NM
    Psychol Med; 1978 Aug; 8(3):471-82. PubMed ID: 30106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for dopamine release and metabolism beyond the control of nerve impulses and dopamine receptors in rat substantia nigra.
    Nissbrandt H; Pileblad E; Carlsson A
    J Pharm Pharmacol; 1985 Dec; 37(12):884-9. PubMed ID: 2868096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The turnover rate of gamma-aminobutyric acid in the nuclei of telencephalon: implications in the pharmacology of antipsychotics and of a minor tranquilizer.
    Mao CC; Marco E; Revuelta A; Bertilsson L; Costa E
    Biol Psychiatry; 1977 Jun; 12(3):359-71. PubMed ID: 17436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biphasic and opposite effects of dopamine and apomorphine on endogenous GABA release in the rat substantia nigra.
    van der Heyden JA; Venema K; Korf J
    J Neurochem; 1980 Jan; 34(1):119-25. PubMed ID: 6778956
    [No Abstract]   [Full Text] [Related]  

  • 30. Chronic haloperidol administration enhances the gamma-aminobutyric acid level in the rat striatum without altering the glutamate level.
    Kornhuber J; Kim JS; Kornhuber ME; Kornhuber HH
    Eur Neurol; 1984; 23(4):269-73. PubMed ID: 6541578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrophysiological and behavioral assessments of dopamine autoreceptor activation to apomorphine in rats.
    Okuyama S; Shimamura H; Hashimoto S; Aihara H
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):246-54. PubMed ID: 3827410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of striatal dopamine receptors induces pain inhibition in rats.
    Lin MT; Wu JJ; Chandra A; Tsay BL
    J Neural Transm; 1981; 51(3-4):213-22. PubMed ID: 7288429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation.
    Lindefors N; Brodin E; Tossman U; Segovia J; Ungerstedt U
    Exp Brain Res; 1989; 74(3):527-34. PubMed ID: 2468514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for dopamine autoreceptors controlling dopamine synthesis in the substantia nigra.
    Argiolas A; Melis MR; Fadda F; Gessa GL
    Brain Res; 1982 Feb; 234(1):177-81. PubMed ID: 6800566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apomorphine increases glucose utilization in the substantia nigra, subthalamic nucleus and corpus striatum of rat.
    Brown LL; Wolfson LI
    Brain Res; 1978 Jan; 140(1):188-93. PubMed ID: 626883
    [No Abstract]   [Full Text] [Related]  

  • 36. Relative involvement of globus pallidus and subthalamic nucleus in the regulation of somatodendritic dopamine release in substantia nigra is dopamine-dependent.
    Cobb WS; Abercrombie ED
    Neuroscience; 2003; 119(3):777-86. PubMed ID: 12809698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo voltammetric study of dopamine release in the striatum following microinjection of apomorphine into the substantia nigra zona reticulata.
    Kamata K; Sugimoto A; Kameyama T
    Jpn J Pharmacol; 1986 Mar; 40(3):472-7. PubMed ID: 3712872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of haloperidol and low dose clozapine on the acetylcholine turnover rate in rat forebrain structures.
    Bluth R; Langnickel R
    Biomed Biochim Acta; 1985; 44(10):1531-9. PubMed ID: 4084256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: analysis using in vivo intracellular recording.
    Grace AA; Bunney BS
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1092-100. PubMed ID: 3746660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substantia nigra as an out-put station for striatal dopaminergic responses: role of a GABA-mediated inhibition of pars reticulata neurons.
    Di Chiara G; Porceddu ML; Morelli M; Mulas ML; Gessa GL
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Mar; 306(2):153-9. PubMed ID: 571967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.